103 related articles for article (PubMed ID: 18564791)
1. DNA analysis and malignant hyperthermia susceptibility.
Stowell KM; Pollock N
Anaesth Intensive Care; 2008 May; 36(3):305-7. PubMed ID: 18564791
[No Abstract] [Full Text] [Related]
2. Identification of genetic mutations in Australian malignant hyperthermia families using sequencing of RYR1 hotspots.
Gillies RL; Bjorksten AR; Davis M; Du Sart D
Anaesth Intensive Care; 2008 May; 36(3):391-403. PubMed ID: 18564801
[TBL] [Abstract][Full Text] [Related]
3. Special article: Future directions in malignant hyperthermia research and patient care.
Hirshey Dirksen SJ; Larach MG; Rosenberg H; Brandom BW; Parness J; Lang RS; Gangadharan M; Pezalski T
Anesth Analg; 2011 Nov; 113(5):1108-19. PubMed ID: 21709147
[TBL] [Abstract][Full Text] [Related]
4. Malignant hyperthermia.
Larach MG
Science; 1992 Jul; 257(5066):11-2. PubMed ID: 1621085
[No Abstract] [Full Text] [Related]
5. Increasing the number of diagnostic mutations in malignant hyperthermia.
Levano S; Vukcevic M; Singer M; Matter A; Treves S; Urwyler A; Girard T
Hum Mutat; 2009 Apr; 30(4):590-8. PubMed ID: 19191329
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetic detection of susceptibility to malignant hyperthermia in Belgian families.
Heytens L
Acta Anaesthesiol Belg; 2007; 58(2):113-8. PubMed ID: 17710899
[TBL] [Abstract][Full Text] [Related]
7. Correlations between genotype and pharmacological, histological, functional, and clinical phenotypes in malignant hyperthermia susceptibility.
Monnier N; Kozak-Ribbens G; Krivosic-Horber R; Nivoche Y; Qi D; Kraev N; Loke J; Sharma P; Tegazzin V; Figarella-Branger D; Roméro N; Mezin P; Bendahan D; Payen JF; Depret T; Maclennan DH; Lunardi J
Hum Mutat; 2005 Nov; 26(5):413-25. PubMed ID: 16163667
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel mutation in the ryanodine receptor gene (RYR1) in patients with malignant hyperthermia.
Rueffert H; Kraus H; Olthoff D; Deutrich C; Froster UG
Hum Mutat; 2001 Mar; 17(3):238. PubMed ID: 11241852
[No Abstract] [Full Text] [Related]
9. Malignant hyperthermia in China.
Xu ZH; Luo AL; Guo XY; Ren HZ; Wang YL; Zhang X; Huang YG; Ye TH
Anesth Analg; 2006 Oct; 103(4):983-5. PubMed ID: 17000816
[TBL] [Abstract][Full Text] [Related]
10. Screening for mutations in the RYR1 gene in families with malignant hyperthermia.
Muniz VP; Silva HC; Tsanaclis AM; Vainzof M
J Mol Neurosci; 2003; 21(1):35-42. PubMed ID: 14500992
[TBL] [Abstract][Full Text] [Related]
11. Detecting susceptibility to malignant hyperthermia.
Ellis FR
BMJ; 1992 Mar; 304(6830):791-2. PubMed ID: 1392703
[No Abstract] [Full Text] [Related]
12. [Malignant hyperthermia: case-finding of subjects at risk].
Viering WA; Sengers RC; Stadhouders AM; Gielen MJ; Festen C
Ned Tijdschr Geneeskd; 1986 May; 130(22):1002-4. PubMed ID: 3724881
[No Abstract] [Full Text] [Related]
13. [Malignant hyperthermia: difficulty in diagnosing susceptibility in Spain].
Montes A; Ramos R; Trillo L; Silva T; Puig MM
Rev Esp Anestesiol Reanim; 1999 Mar; 46(3):130-2. PubMed ID: 10228380
[No Abstract] [Full Text] [Related]
14. Difficult diagnosis of malignant hyperthermia during laparoscopic surgery.
Freiermuth D; Poblete B; Singer M; Konrad CJ; Girard T
Eur J Anaesthesiol; 2013 Oct; 30(10):635-8. PubMed ID: 23736090
[No Abstract] [Full Text] [Related]
15. European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility.
Hopkins PM; Rüffert H; Snoeck MM; Girard T; Glahn KP; Ellis FR; Müller CR; Urwyler A;
Br J Anaesth; 2015 Oct; 115(4):531-9. PubMed ID: 26188342
[TBL] [Abstract][Full Text] [Related]
16. Ambulatory laboratory investigations for malignant hyperthermia susceptible patients.
Ellis FR
Acta Anaesthesiol Belg; 1988; 39(3 Suppl 2):253-4. PubMed ID: 3176861
[No Abstract] [Full Text] [Related]
17. Functional properties of RYR1 mutations identified in Swedish patients with malignant hyperthermia and central core disease.
Vukcevic M; Broman M; Islander G; Bodelsson M; Ranklev-Twetman E; Müller CR; Treves S
Anesth Analg; 2010 Jul; 111(1):185-90. PubMed ID: 20142353
[TBL] [Abstract][Full Text] [Related]
18. How carefully can we phenotype patients suspected of malignant hyperthermia susceptibility?
Larach MG; MacLennan DH
Anesthesiology; 1999 Mar; 90(3):645-8. PubMed ID: 10078661
[No Abstract] [Full Text] [Related]
19. [What significance to genotype changes have in diagnosis of malignant hyperthermia?].
Steinfath M; Scholz J; Singh S; Wappler F
Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Aug; 31(6):334-43. PubMed ID: 8962927
[TBL] [Abstract][Full Text] [Related]
20. [Malignant hyperthermia--diagnostics, treatment and anaesthetic management].
Schuster F; Müller-Reible CR
Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Nov; 44(11-12):758-63; quiz 764. PubMed ID: 19918708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
